publication date: Jan. 10, 2020

In Brief

Thomas J. Lynch Jr. named president and director of Fred Hutch

Thomas J. Lynch Jr. was named president and director of Fred Hutchinson Cancer Research Center Jan 7.

Lynch,an expert in solid tumor research, precision medicine and immuno-oncology whose career has spanned academic oncology and pharma industry, will join Fred Hutch Feb. 1.

Lynch has served as chairman and CEO of Massachusetts General Physicians Organization, director of Yale Cancer Center, physician-in-chief of Yale’s Smilow Cancer Hospital, professor of medicine at Yale School of Medicine, chief of Hematology-Oncology at Massachusetts General Hospital and professor of medicine at Harvard Medical School.

Most recently, Lynch was the chief scientific officer at Bristol-Myers Squibb, where he led research and development in cancer, cardiovascular disease, fibrosis and immunoscience. Lynch is credited with enhancing the company’s scientific depth, particularly in the area of translational immuno-oncology research, resulting in new therapies and treatments for patients with both solid tumors and hematologic malignancies.

While at Mass General, Lynch was part of the research team that discovered how targeted therapies could dramatically change outcomes for lung cancer patients with mutations in the EGFR gene.

“The Hutch is legendary for being where breakthrough discoveries in basic science happen. This institution is unafraid to do what science is best at: taking bold, unconventional approaches to solving hard problems. The Hutch is well-positioned to make an enormous difference in how patients and caregivers manage cancer and related diseases,” Lynch said in a statement. “In the next five years we’re going to make remarkable leaps. Technology and personalized diagnostics can accelerate our understanding of the molecular underpinnings of cancer.”

In 1995, Lynch was a … Continue reading Thomas J. Lynch Jr. named president and director of Fred Hutch

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.